RESUMEN
Recent studies have shown that local injection of secukinumab can achieve positive therapeutic effects when applied in the treatment of nail psoriasis. At present, there have been no other studies on the use of biological agents in the treatment of pediatric nail psoriasis. Three children were included in the study to evaluate the efficacy and safety of periungual injection and long-term injection of secukinumab in the treatment of nail psoriasis in children. It was found that local injection did not achieve a remarkable therapeutic effect. The nail lesions were improved continuously by subcutaneous injection once a month.
Asunto(s)
Anticuerpos Monoclonales Humanizados , Inyecciones Intralesiones , Enfermedades de la Uña , Psoriasis , Humanos , Psoriasis/tratamiento farmacológico , Anticuerpos Monoclonales Humanizados/administración & dosificación , Anticuerpos Monoclonales Humanizados/uso terapéutico , Enfermedades de la Uña/tratamiento farmacológico , Niño , Masculino , Femenino , Resultado del Tratamiento , Adolescente , Inyecciones Subcutáneas , Uñas/efectos de los fármacosRESUMEN
In this study, it was aimed to describe isotretinoin-induced nail changes and increase patients' treatment compliance. A total of 200 patients diagnosed with acne vulgaris were included in the study. 100 of the patients were started systemic isotretinoin treatment and 100 control patients were receiving topical acne treatment. Age and gender of all of the participants, duration of treatment, total doses per month, and type of nail changes were recorded. Patients with persistent nail changes were followed at the 3rd and 6th months after treatment. A total of 34 patients had nail changes in the isotretinoin group. These changes included onychoschizia (55.9%), leukonychia (11.8%), onychorexis (8.8%), median nail dystrophy (5.9%), pyogenic granulomas (5.9%), chronic paronychia and granulation tissue (5.9%), onycholysis (2.9%) and Beau's line (2.9%). The rate of nail changes in the isotretinoin group was significantly higher than in the topical treatment group (34% vs. 11%, p:0.001). Isotretinoin increases the risk of nail changes, primarily onychoschizia. The risk of developing nail changes is not associated with treatment duration but is associated with the total cumulative dose. Nail findings induced by isotretinoin are completely reversible.
Asunto(s)
Acné Vulgar , Fármacos Dermatológicos , Isotretinoína , Enfermedades de la Uña , Uñas , Humanos , Isotretinoína/efectos adversos , Femenino , Masculino , Enfermedades de la Uña/inducido químicamente , Enfermedades de la Uña/patología , Acné Vulgar/tratamiento farmacológico , Adolescente , Adulto , Adulto Joven , Uñas/efectos de los fármacos , Uñas/patología , Fármacos Dermatológicos/efectos adversos , Fármacos Dermatológicos/uso terapéuticoRESUMEN
Candida parapsilosis was introduced as the second most responsible for nail involvement. The colonization of biotic and abiotic surfaces by Candida spp. can result in the formation of biofilms, which possess a high level of resistance to typical antifungal agents. Since Candida spp. can produce biofilm mass on the surface of the nails, dermatologists should consider appropriate antifungals to eliminate both the planktonic and biofilm cells. The aim of this research was to determine the antifungal efficacy of itraconazole against C. parapsilosis sensu lato biofilm formations, in addition to its static effects. Ten C. parapsilosis sensu lato isolates were enrolled in this study. The use of itraconazole results in the accumulation of reactive oxygen species (ROS) during treatment. In order to verify the correlation between ROS and itraconazole-induced cell death, the viability of cells was analyzed by administering the ROS scavenger Ascorbic acid. The apoptotic features of itraconazole were analyzed using the Annexin V-FITC method. Based on current data, it was found that the generation of intracellular stresses by itraconazole is not observed in cells upon ROS inhibition, emphasizing the importance of intracellular ROS in the apoptotic mechanism of itraconazole. Targeting the oxidative defense system is a powerful point to use ROS-inducing antifungals as a superior choice for more effective therapies in case of recalcitrant onychomycosis.
Asunto(s)
Antifúngicos , Biopelículas , Candida parapsilosis , Farmacorresistencia Fúngica , Itraconazol , Onicomicosis , Especies Reactivas de Oxígeno , Itraconazol/farmacología , Humanos , Biopelículas/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Onicomicosis/tratamiento farmacológico , Onicomicosis/microbiología , Antifúngicos/farmacología , Farmacorresistencia Fúngica/efectos de los fármacos , Candida parapsilosis/efectos de los fármacos , Candida parapsilosis/aislamiento & purificación , Apoptosis/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Femenino , Uñas/microbiología , Uñas/efectos de los fármacosRESUMEN
BACKGROUND: A healthy skin provides protection against intrinsic and extrinsic factors. Skin aging is characterized by structural and morphological alterations affecting skin health, integrity, and functionality, resulting in visible aging signs. AIM: The primary objective of this study was to assess the effect of a collagen peptide dietary supplement on skin aging in the East Asian population. METHODS: Eighty-five healthy women, aged from 43 to 65 years old, were randomly assigned to the collagen supplement (CP, 5 g) or placebo (maltodextrin, 5 g) group. To standardize daily skin care, the volunteers in both groups used a specific face cream for 28 days prior to and throughout the supplementation period, creating an equal baseline for the assessment of the efficacy of CP on several skin parameters. At baseline, day 28 and day 84, the following hallmarks of skin and nail aging were assessed: dermis density, skin moisture and elasticity, wrinkle visibility, beauty perception, and nail color. RESULTS: After 84 days, a significant improvement of dermis density and skin moisture was observed in the collagen peptides group compared to the placebo group. Positive effects on skin elasticity, wrinkle visibility, nail color, and overall beauty perception were already observed within 28 days of supplementation in the CP group, while the same effects in the placebo group were only observed after 84 days. CONCLUSION: Taken together, these results show that, in addition to a standardized skin care, daily supplementation with 5 g of collagen peptides positively affects visible signs of skin and nail aging in the East Asian population.
Asunto(s)
Suplementos Dietéticos , Uñas , Envejecimiento de la Piel , Adulto , Anciano , Femenino , Humanos , Persona de Mediana Edad , Colágeno/administración & dosificación , Dermis/efectos de los fármacos , Método Doble Ciego , Pueblos del Este de Asia , Elasticidad/efectos de los fármacos , Uñas/efectos de los fármacos , Piel/efectos de los fármacos , Envejecimiento de la Piel/efectos de los fármacosRESUMEN
Hair and nail cortisol is increasingly studied as a physiologic proxy for chronic stress response. Glucocorticoid use is an expected confounder for cortisol measurement, yet there remains little evidence of whether external cortisol use should be subject to exclusion in study subjects. In a group of 209 youth (15-22 year-olds), we analyzed hair and fingernail cortisol concentrations. We assessed topical, nasal, oral, and injectable glucocorticoid use via a questionnaire. Extensively validated methods were used for hair and nail cortisol extraction and measurements. The median value of hair cortisol was 10.2â¯pg/mg (n=200), and the median value of nail cortisol was 7.06â¯pg/mg (n=203). Topical glucocorticoid use significantly increased hair and nail cortisol concentrations (p<0.005). Hair and nail cortisol concentrations were positively associated (p<0.0001, n=194). Spearman correlation coefficients demonstrated that the positive correlation between hair and nail cortisol values was higher in participants who used external glucocorticoids. Topical glucocorticoids moderated the association between hair and nail cortisol values (p=0.006). Based on these findings, we recommend that the assessment of topical glucocorticoid use must be performed when collecting hair/nail samples and that subjects reporting glucocorticoid use should be excluded from all future hair and nail cortisol studies; also, all outliers must be excluded to account for glucocorticoid medication underreporting and yet-unknown confounders.
Asunto(s)
Glucocorticoides , Cabello , Hidrocortisona , Uñas , Humanos , Cabello/química , Uñas/química , Uñas/metabolismo , Uñas/efectos de los fármacos , Hidrocortisona/análisis , Hidrocortisona/metabolismo , Glucocorticoides/análisis , Masculino , Femenino , Adolescente , Adulto Joven , AdultoRESUMEN
Commercial topical formulations containing itraconazole (poorly water soluble), for mycotic infections, have poor penetration to infection sites beneath the nails and skin thereby necessitating oral administration. To improve penetration, colloidal solutions of itraconazole (G1-G4) containing Poloxamer 188, tween 80, ethanol, and propylene glycol were prepared and incorporated into HFA-134-containing sprays. Formulations were characterized using particle size, drug content, and Fourier-transform infrared spectroscopy (FTIR). In vitro permeation studies were performed using Franz diffusion cells for 8 h. Antimycotic activity on Candida albicans and Trichophyton rubrum was performed using broth micro-dilution and flow cytometry, while cytotoxicity was tested on HaCaT cell lines. Particle size ranged from 39.35-116.80 nm. FTIR and drug content revealed that G1 was the most stable formulation (optimized formulation). In vitro release over 2 h was 45% for G1 and 34% for the cream. There was a twofold increase in skin permeation, fivefold intradermal retention, and a sevenfold increase in nail penetration of G1 over the cream. Minimum fungicidal concentrations (MFC) against C. albicans were 0.156 and 0.313 µg/mL for G1 and cream, respectively. The formulations showed optimum killing kinetics after 48 h. MFC values against T. rubrum were 0.312 and 0.625 µg/mL for the G1 and cream, respectively. Transmission electron microscopy revealed organelle destruction and cell leakage for G1 in both organisms and penetration of keratin layers to destroy T. rubrum. Cytotoxicity evaluation of G1 showed relative safety for skin cells. The G1 formulation showed superior skin permeation, nail penetration, and fungicidal activity compared with the cream formulation.
Asunto(s)
Antifúngicos , Candida albicans , Coloides , Itraconazol , Antifúngicos/farmacología , Antifúngicos/administración & dosificación , Candida albicans/efectos de los fármacos , Itraconazol/farmacología , Itraconazol/administración & dosificación , Itraconazol/química , Humanos , Animales , Trichophyton/efectos de los fármacos , Pruebas de Sensibilidad Microbiana/métodos , Química Farmacéutica/métodos , Tamaño de la Partícula , Piel/metabolismo , Piel/efectos de los fármacos , Piel/microbiología , Absorción Cutánea/efectos de los fármacos , Línea Celular , Células HaCaT , Uñas/efectos de los fármacos , Uñas/microbiología , Uñas/metabolismo , ArthrodermataceaeRESUMEN
BACKGROUND: Collagen, a key protein in the body maintains hair, skin and bone health and its production tends to decrease in synthesis as humans age. The demand for vegan collagen-builder has increased worldwide due to increased adaptability to vegan diet. OBJECTIVE: This clinical study was designed aim to evaluate the safety and efficacy of vegan collagen builder (VEGCOL™ï¸) at different dosages (2.5, 5, and 10 g) in adult participants. METHODS: Total 66 subjects (22 subjects/dose) aged 30 to 50 years were enrolled, and 63 subjects completed the study. Duration of study was 60 days. Evaluations included change in skin elasticity, hydration, crow's feet area wrinkles, fine lines, skin, Glogau skin age, change in pain scale score, muscle strength and subject perception assessment about test treatment use. RESULTS: After 60 days of treatment, there was significant improvement in hair growth rate by 45.01%, 38.54% and 50.37% with p < 0.01 for doses 2.5, 5, and 10 g respectively. Additionally, 19.64% (p < 0.0001) and 20.51% (p < 0.0001) increase in hair density and hair thickness respectively was observed with 10 g dose. 2.5 g dose resulted in 33.03% (p < 0.01) increase in skin smoothness and 49.94% (p < 0.0001) decrease in crow's feet area wrinkles, decreased retraction time by 21.71 milliseconds (p < 0.05). 52.54% reduction in pain score (p < 0.001). No any adverse events were reported. CONCLUSION: Vegan collagen-builder effectively improved multiple age-related concerns such as wrinkles, fine lines, joint pain, muscle strength and hair growth. All respondents perceived the product as beneficial in improving the aesthetics of the skin, hair, and nails. The findings support the use of vegan collagen-builder as safe and efficacious in promoting healthier skin, stronger muscles, and improved hair and nail conditions.
Asunto(s)
Colágeno , Cabello , Envejecimiento de la Piel , Humanos , Persona de Mediana Edad , Adulto , Colágeno/administración & dosificación , Femenino , Envejecimiento de la Piel/efectos de los fármacos , Cabello/efectos de los fármacos , Cabello/crecimiento & desarrollo , Masculino , Uñas/efectos de los fármacos , Veganos , Belleza , Fuerza Muscular/efectos de los fármacos , Piel/efectos de los fármacos , Elasticidad/efectos de los fármacosRESUMEN
Manganese is an essential element but can be neurotoxic if overexposed. Our previous study found that a higher level of manganese in nail biomarkers from children living near coal ash storage sites was associated with poorer neurobehavioral function. Children living near this type of pollution may be exposed to other metal neurotoxicants and a better understanding of manganese in the context of multiple exposures is needed. Mixture analyses were completed using nail samples from 251 children aged 6-14 years old. These biomarkers containing metals known to impact brain functioning were investigated to test our hypothesis that a mixture of metals including manganese impacts the development of children living near coal ash sites. Nails collected from children were analyzed using ICP-MS for manganese, arsenic, cadmium, lead, and zinc based on previous research on neurotoxicity. Bayesian kernel machine regression (BKMR) was used while adjusting for age, sex, and maternal education as potential covariates. Children also completed the Behavioral Assessment Research System (BARS) to provide neurobehavioral measures of attention and processing speed as outcomes for mixture analyses. Metal mixture analyses indicated that the relationship of manganese concentration and attention and processing speed was moderated by arsenic.,. When nail biomarkers for arsenic were highest (90th percentile), manganese was associated with poorer neurobehavioral performance on the BARS, measured by CPT hit latency. At low levels of arsenic (10th percentile), there was no evidence of harmful effects from overexposure to manganese on CPT hit latency based on BKMR analysis. Previously reported effects of manganese on neurobehavioral function may be moderated by arsenic exposure. Metal exposures and behavior outcomes can be studied with mixture analyses such as BKMR to evaluate effects of simultaneous exposures on children exposed to pollution.
Asunto(s)
Arsénico , Ceniza del Carbón , Exposición a Riesgos Ambientales , Manganeso , Uñas , Humanos , Niño , Femenino , Arsénico/toxicidad , Masculino , Manganeso/toxicidad , Uñas/química , Uñas/efectos de los fármacos , Adolescente , Exposición a Riesgos Ambientales/efectos adversos , Pruebas Neuropsicológicas , Atención/efectos de los fármacos , Plomo/toxicidad , BiomarcadoresRESUMEN
Exposure at conception to phenytoin (PHT), phenobarbital (PB), and carbamazepine (CBZ) has been associated with several different effects on the fetus, including hypoplasia of the distal phalanges, dysmorphic facial features, and structural abnormalities such as oral clefts and neural tube defects. One question is whether each of these antiepileptic drugs (AEDs) has the same effects or just similar effects. A systematic examination of the fingers of children exposed at conception to PHT, PB, or CBZ, as monotherapy, has been used to address this question. The findings in the examinations of the fingers of 115 AED-exposed children (40, PHT; 34, PB; 41, CBZ) and their parents were compared to the findings in 111 age- and sex-matched children and their parents. The evaluations used were both subjective assessments and objective measurements. Shortening and narrowing of the fifth fingernail and an increased frequency of arch patterns in the dermal ridges were more common in PHT-exposed children. A significant decrease in the length of the nail, but not width, occurred in the PB-exposed children. Stiffness of the interphalangeal joints was more common in the CBZ-exposed children. The findings in children exposed to PHT, PB, or CBZ, as monotherapy, showed that all three exposures in early pregnancy affected the fingers, but the effects were not the same. The most striking effects were present in PHT-exposed children.
Asunto(s)
Anticonvulsivantes , Carbamazepina , Dedos , Fenobarbital , Fenitoína , Efectos Tardíos de la Exposición Prenatal , Humanos , Carbamazepina/efectos adversos , Fenitoína/efectos adversos , Femenino , Fenobarbital/efectos adversos , Embarazo , Dedos/anomalías , Anticonvulsivantes/efectos adversos , Anticonvulsivantes/uso terapéutico , Masculino , Efectos Tardíos de la Exposición Prenatal/inducido químicamente , Efectos Tardíos de la Exposición Prenatal/patología , Niño , Anomalías Inducidas por Medicamentos/patología , Preescolar , Uñas/efectos de los fármacos , Uñas/patología , LactanteRESUMEN
The main purpose of this work was to determine if the use of hybrid nail polishes causes changes in concentration of the most important sulfur amino acids that build nail plate structures, cysteine and methionine. We found that the average contents of cysteine and methionine in studied samples before the use of hybrid manicure were 1275.3 ± 145.9 nmol mg-1 and 111.7 ± 23.8 nmol mg-1, respectively. After six months of hybrid manicure use, the average amount of these sulfur amino acids in studied samples were 22.1% and 36.5% lower in the case of cysteine and methionine, respectively. The average amounts of cysteine and methionine in nail plate samples after the use of hybrid manicures were 992.4 ± 96.2 nmol mg-1 and 70.9 ± 14.8 nmol mg-1, respectively. We also confirmed that in studied women the application of UV light varnishes reduced the thickness of the nail plate, from 0.50 ± 0.12 mm before to 0.46 ± 0.12 mm after the use of the hybrid manicure.
Asunto(s)
Cisteína/análisis , Aceites Industriales/efectos adversos , Metionina/análisis , Uñas/efectos de los fármacos , Uñas/efectos de la radiación , Rayos Ultravioleta/efectos adversos , Adolescente , Adulto , Cromatografía Líquida de Alta Presión , Cisteína/metabolismo , Femenino , Humanos , Metionina/metabolismo , Persona de Mediana Edad , Uñas/metabolismo , Factores de TiempoAsunto(s)
Anticuerpos Monoclonales Humanizados/farmacología , Dermatitis Atópica/tratamiento farmacológico , Anticuerpos Monoclonales Humanizados/uso terapéutico , Dermatitis Atópica/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Uñas/efectos de los fármacos , Uñas/fisiopatología , Resultado del TratamientoRESUMEN
BACKGROUND: Paronychia is a common toxicity associated with targeted anticancer therapies. Antibiotics and steroids are the standard treatments for severe paronychia, yet they are often inadequate, prolonging the patient's suffering and resulting in changes to effective cancer therapy. OBJECTIVE: This article describes the clinical course of drug-induced paronychia and attempts to identify circumstances under which nail surgery may be beneficial. MATERIALS AND METHODS: This is a retrospective case series from a single institution's electronic medical record for patients on paronychia-inducing anticancer therapies with nail disease visit diagnosis codes. RESULTS: The authors identified 36 nail procedures performed on 12 patients, all of whom were managed with conservative steroid and antibiotic therapy with varying degrees of improvement; however, no further improvement was seen after 90 days. Partial matricectomy, nail avulsion, debridement/clipping, and incision and drainage were performed with resolution rates of 100% (11/11), 38.5% (5/13), 12.5% (1/8), and 0% (0/4), respectively. The average time to surgical intervention was 196 days, and the average time to resolution was 268 days. CONCLUSION: This series highlights the prolonged course of severe drug-induced paronychia and the importance of surgical intervention to reduce pain and impact on cancer treatment. Partial matricectomy should be considered for paronychia unresponsive to conservative therapy by 3 months.
Asunto(s)
Antineoplásicos/efectos adversos , Drenaje/métodos , Neoplasias/tratamiento farmacológico , Paroniquia/cirugía , Adulto , Anciano , Antibacterianos/administración & dosificación , Terapia Combinada , Femenino , Glucocorticoides/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Terapia Molecular Dirigida/efectos adversos , Terapia Molecular Dirigida/métodos , Uñas/efectos de los fármacos , Uñas/inmunología , Uñas/patología , Paroniquia/inducido químicamente , Paroniquia/diagnóstico , Paroniquia/inmunología , Estudios Retrospectivos , Piel/efectos de los fármacos , Piel/inmunología , Piel/patología , Resultado del TratamientoRESUMEN
Urea has been incorporated into several topical ungual formulations to hydrate and soften the nail plate. In this study, we employed various characterization techniques (visual observation, scanning electron microscopy, measurement of thickness, transonychial water loss, nail electrical resistance, and mechanical study) to investigate the effect of urea concentration on the hydration of bovine hoof membranes - an in vitro model of infected human nails. We obtained inconsistent results in the thickness, transonychial water loss, nail electrical resistance, and scanning electron microscopy studies. In the mechanical study using a modified Texture Analyzer method, we reported an inverse and linear correlation between urea concentrations in the formulations and the force required to puncture the treated membrane (R2 = 0.9582, n ≥ 8). As the urea concentration decreased from 4x to 2x, 1x, and 0x % w/w, the puncture force increased significantly from 0.47 ± 0.07 to 0.77 ± 0.07, 0.91 ± 0.09, and 1.33 ± 0.26 N, respectively (p < 0.05). Thus, urea provided a positive softening effect on the membranes and the puncture force could indicate the urea level in topical formulations. In this study, we provided a novel, efficient, and reliable tool to evaluate the hydration level and physical properties of bovine hoof membranes.
Asunto(s)
Pezuñas y Garras/efectos de los fármacos , Uñas/efectos de los fármacos , Onicomicosis/tratamiento farmacológico , Urea/farmacología , Administración Tópica , Animales , Bovinos , Química Farmacéutica , Modelos Animales de Enfermedad , Impedancia Eléctrica , Pezuñas y Garras/metabolismo , Humanos , Microscopía Electrónica de Rastreo , Uñas/metabolismo , Urea/administración & dosificaciónRESUMEN
We evaluated a hydroalcoholic extract of Sapindus saponaria L. pericarps (ETHOSS), as a candidate to a topical antifungal medicine for onychomycosis. ETHOSS was produced by extracting the crushed fruits in ethanol. The saponin contents were identified and characterized by electrospray ionization mass spectrometry. We measured the in vitro antifungal activity against three dermatophyte fungi, isolated from onychomycosis: Trichophyton rubrum, T. mentagrophytes, and T. interdigitale, using broth microdilution tests. The minimum fungicide concentration of ETHOSS ranged from 195.31 to 781.25 µg/mL. The cytotoxicity of the crude extract was tested on the HeLa cell line, and its ability to permeate into healthy human nails by photoacoustic spectroscopy and Fourier transformation infrared spectrometer (FTIR) spectroscopy by attenuated total reflection. Besides its strong antifungal activity, ETHOSS showed low cytotoxicity in human cells. It was able to permeate and reach the full thickness of the nail in one hour, without the aid of facilitating vehicles, and remained there for at least 24 h. These results suggest that ETHOSS has great potential for treating onychomycosis.
Asunto(s)
Alcoholes/química , Antifúngicos/farmacología , Uñas/efectos de los fármacos , Extractos Vegetales/farmacología , Saponaria/química , Saponinas/farmacología , Adulto , Femenino , Humanos , Uñas/metabolismoAsunto(s)
Amidas/uso terapéutico , Antivirales/uso terapéutico , Tratamiento Farmacológico de COVID-19 , Uñas/efectos de los fármacos , Neumonía Viral/tratamiento farmacológico , Pirazinas/uso terapéutico , COVID-19/epidemiología , Humanos , Luminiscencia , Neumonía Viral/epidemiología , Neumonía Viral/virología , SARS-CoV-2 , Turquía/epidemiología , Rayos UltravioletaRESUMEN
Dermatophytoses are inflammatory cutaneous mycoses caused by dermatophyte fungi of the genera Trichophyton, Microsporum, and Epidermophyton that affect both immunocompetent and immunocompromised individuals. With therapeutic failure, dermatophytoses can become chronic and recurrent. This is partly due to their ability to develop biofilms, microbial communities involved in a polymeric matrix attached to biotic or abiotic surfaces, contributing to fungal resistance. This review presents evidence accumulated in recent years on antidermatophyte biofilm activity. The following databases were used: Web of Science, Medline/PubMed (via the National Library of Medicine), Embase, and Scopus. Original articles published between 2011 and 2020, emphasizing the antifungal activity of conventional and new drugs against dermatophyte biofilms were eligible. A total of 11 articles met the inclusion criteria and were reviewed - the studies used in vitro and ex vivo (fragments of nails and hair) experimental models. The articles focused on reports of antibiofilm activity for conventional antifungals, natural drugs, and new therapeutic tools. The strains reported on were T. mentagrophytes, T. rubrum, T. tonsurans, M. canis, and M. gypseum. Between the studies, the wide variability of experimental conditions in vitro and ex vivo was observed. The data suggest the need for methodological standardization (at some minimum). This review systematically presents current studies involving agents that present antibiofilm activity against dermatophytes; and an overview of the ideal in vitro and ex vivo experimental conditions to guarantee biofilm formation that may assist future research. LAY ABSTRACT: This review presents the current studies on the antibiofilm activities of drugs against dermatophytes and ideal experimental conditions, which might guarantee in vitro and ex vivo biofilm formation. It can be useful to examine the efficacy of new antimicrobial drugs against dermatophytes.
Asunto(s)
Antifúngicos/farmacología , Arthrodermataceae/efectos de los fármacos , Biopelículas/efectos de los fármacos , Arthrodermataceae/fisiología , Dermatomicosis/tratamiento farmacológico , Cabello/efectos de los fármacos , Cabello/microbiología , Humanos , Pruebas de Sensibilidad Microbiana , Uñas/efectos de los fármacos , Uñas/microbiologíaRESUMEN
Iontophoresis is a widely used drug delivery technique that has been used clinically to improve permeation through the skin for drugs and other actives in topical formulations. It is however not commonly used for the treatment of nail diseases despite its potential to improve transungual nail delivery. Instead, treatments for nail diseases are limited to relatively ineffective topical passive permeation techniques, which often result in relapses of nail diseases due to the thickness and hardness of the nail barrier resulting in lower permeation of the actives. Oral systemic antifungal agents that are also used are often associated with various undesirable side effects resulting in low patient compliance. This review article discusses what is currently known about the field of transungual iontophoresis, providing evidence of its efficacy and practicality in delivering drug to the entire surface of the nail for extended treatment periods. It also includes relevant details about the nail structure, the mechanisms of iontophoresis, and the associated in vitro and in vivo studies which have been used to investigate the optimal characteristics for a transungual iontophoretic drug delivery system. Iontophoresis is undoubtedly a promising option to treat nail diseases, and the use of this technique for clinical use will likely improve patient outcomes.Graphical abstract.